Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development
-
Published:2022-09-09
Issue:1
Volume:5
Page:
-
ISSN:2399-3642
-
Container-title:Communications Biology
-
language:en
-
Short-container-title:Commun Biol
Author:
Sobral DanielORCID, Martins MartaORCID, Kaplan ShannonORCID, Golkaram Mahdi, Salmans Michael, Khan Nafeesa, Vijayaraghavan Raakhee, Casimiro SandraORCID, Fernandes Afonso, Borralho Paula, Ferreira Cristina, Pinto RuiORCID, Abreu Catarina, Costa Ana Lúcia, Zhang Shile, Pawlowski Traci, Godsey Jim, Mansinho AndréORCID, Macedo Daniela, Lobo-Martins Soraia, Filipe Pedro, Esteves Rui, Coutinho João, Costa Paulo MatosORCID, Ramires Afonso, Aldeia Fernando, Quintela António, So Alex, Liu LiORCID, Grosso Ana RitaORCID, Costa LuisORCID
Abstract
AbstractColorectal cancer (CRC) is a highly diverse disease, where different genomic instability pathways shape genetic clonal diversity and tumor microenvironment. Although intra-tumor heterogeneity has been characterized in primary tumors, its origin and consequences in CRC outcome is not fully understood. Therefore, we assessed intra- and inter-tumor heterogeneity of a prospective cohort of 136 CRC samples. We demonstrate that CRC diversity is forged by asynchronous forms of molecular alterations, where mutational and chromosomal instability collectively boost CRC genetic and microenvironment intra-tumor heterogeneity. We were able to depict predictor signatures of cancer-related genes that can foresee heterogeneity levels across the different tumor consensus molecular subtypes (CMS) and primary tumor location. Finally, we show that high genetic and microenvironment heterogeneity are associated with lower metastatic potential, whereas late-emerging copy number variations favor metastasis development and polyclonal seeding. This study provides an exhaustive portrait of the interplay between genetic and microenvironment intra-tumor heterogeneity across CMS subtypes, depicting molecular events with predictive value of CRC progression and metastasis development.
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference84 articles.
1. Siegel, R. L. et al. Colorectal cancer statistics, 2020. Ca. Cancer J. Clin. 70, 145–164 (2020). 2. Jones, S. et al. Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl Acad. Sci. USA 105, 4283–4288 (2008). 3. Muzny, D. M. et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012). 4. Giannakis, M. et al. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell Rep. 15, 857–865 (2016). 5. Singh, M. P., Rai, S., Pandey, A., Singh, N. K. & Srivastava, S. Molecular subtypes of colorectal cancer: an emerging therapeutic opportunity for personalized medicine. Genes Dis. 8, 133–145 (2021).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|